Source: International Congress 2019 – Clinical studies of asthma treatments
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Spaziano (NAPLES, Italy), F. Polverino (TUCSON, United States of America), D. Giannattasio (Scafati, Italy), F. Ferrigno (Scafati, Italy), M. Sessa (Copenhagen, Denmark), A. Rossi (NAPLES, Italy), F. Roviezzo (NAPLES, Italy), M. Polverino (Scafati, Italy), B. D'Agostino (NAPLES, Italy). Montelukast induces better control of symptoms and management of lung function, and decreased inflammation in women compared with men.. 2535

Member's Comments

No comment yet.

Related content which might interest you: Clinical characteristics, lung function, quality of life, exercise capacity and inflammatory biomarkers in induced sputum and serum in children and adolescents with uncontrolled severe asthma. Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019 Ensifentrine added on to tiotropium significantly improves lung function, symptoms and QoL in symptomatic COPD patients regardless of baseline reversibility Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more Year: 2020 Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma Source: ERJ Open Res, 6 (1) 00204-2019; 10.1183/23120541.00204-2019 Year: 2020 Current control, airway inflammation, and subsequent exacerbation in patients with asthma Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Intravenous (IV) reslizumab improves asthma control, symptoms, and quality of life in patients with historically elevated blood eosinophils Source: International Congress 2018 – Innovative therapies in asthma and COPD Year: 2018 Small airways function: evaluation in a population of adult patients with severe asthma and potential use as a response biomarker for anti-IL5 therapy Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Leptin levels are associated with reduced lung function in men with COPD Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 Study on levels of high sensitivity C reactive protein in asthmatic patients during exacerbation and remission and its correlation with pulmonary function Source: Annual Congress 2007 - Mechanisms of airway inflammation Year: 2007 Patients with persistent asthma may have poor disease control despite normal lung function: baseline data from a pan-European real-life study Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009 Year: 2009 R667 retinoid agonist modulates blood glucose in COPDe patients with improved metabolic profile compared to ATRA Source: Annual Congress 2007 - New drugs for COPD Year: 2007 Increased self-management capacity leads to improved health outcomes for chronic lung disease patients Source: Eur Respir J 2005; 26: Suppl. 49, 72s Year: 2005 Altered interaction of respiratory muscle activity, flow and lung volume in infants with chronic lung disease compared to healthy controls Source: Annual Congress 2008 - Respiratory physiology in health and disease Year: 2008 The impact of gestation, and its interaction with asthma, on spirometry indices: a longitudinal analysis of lung function in pregnant women with and without asthma. Source: International Congress 2019 – Clinical approach to asthma management Year: 2019 The effect of leukotrienes receptor antagonists on lung function, exercise tolerance and incidence of exacerbations in patients with stable, moderate COPD Source: Eur Respir J 2002; 20: Suppl. 38, 620s Year: 2002 Annual lung function changes in young patients with chronic lung disease Source: Eur Respir J 2002; 19: 886-891 Year: 2002 Respiratory function and airway inflammation in patients with hypothyroidism. The effect of treatment Source: Annual Congress 2009 - Treatment of airways disease Year: 2009 Roflumilast, an oral, once-daily PDE4 inhibitor, improves lung function and reduces exacerbation rates in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 21s Year: 2004 The regulation of apoptosis in the induced sputum cells of patients with bronchial asthma (BA) using different therapeutic programms Source: Eur Respir J 2003; 22: Suppl. 45, 79s Year: 2003 Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with high and low reversibility Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017